RT @l_d_hughes: NEW PAPER: Systematic review of adherence to adjuvant therapy in breast cancer survivors w/@ZMoon15 @RonaMossMorris https:/…
NEW PAPER: Systematic review of adherence to adjuvant therapy in breast cancer survivors w/@ZMoon15 @RonaMossMorris https://t.co/vwxnksZf4F
RT @RonaMossMorris: Why do #BCS stop or alter their adjuvant hormonal meds? Some answers here via @ZMoon15 @l_d_hughes https://t.co/OAfGR…
RT @MedAdherenceOrg: Barriers/facilitators of adjuvant hormone therapy adherence/persistence in women w/breast cancer: systematic review h…
RT @ZMoon15: Factors associated with hormone therapy adherence/persistence in BCS @RonaMossMorris @l_d_hughes @breastcancernow https://t.co…
RT @RonaMossMorris: Why do #BCS stop or alter their adjuvant hormonal meds? Some answers here via @ZMoon15 @l_d_hughes https://t.co/OAfGR…
RT @ZMoon15: Factors associated with hormone therapy adherence/persistence in BCS @RonaMossMorris @l_d_hughes @breastcancernow https://t.co…
RT @ZMoon15: Factors associated with hormone therapy adherence/persistence in BCS @RonaMossMorris @l_d_hughes @breastcancernow https://t.co…
RT @MedAdherenceOrg: Barriers/facilitators of adjuvant hormone therapy adherence/persistence in women w/breast cancer: systematic review h…
Factors associated with hormone therapy adherence/persistence in BCS @RonaMossMorris @l_d_hughes @breastcancernow https://t.co/b4nmjhoWeO
Why do #BCS stop or alter their adjuvant hormonal meds? Some answers here via @ZMoon15 @l_d_hughes https://t.co/OAfGRRIc7F
Barriers/facilitators of adjuvant hormone therapy adherence/persistence in women w/breast cancer: systematic review https://t.co/KgwjAOknLm